Use of testosterone to prevent cyclophosphamide-induced azoospermia.

@article{Masala1997UseOT,
  title={Use of testosterone to prevent cyclophosphamide-induced azoospermia.},
  author={Antonia Masala and Rossana Faedda and Sergio Alagna and Antonio Satta and Giusy Chiarelli and Pier Paolo Rovasio and R. Ivaldi and Maddalena Taras and Elena Lai and Eric Bartoli},
  journal={Annals of internal medicine},
  year={1997},
  volume={126 4},
  pages={292-5}
}
Several cytotoxic agents used to treat neoplastic or immunologic diseases may alter endocrine function in humans [1-5]. In particular, gonadal failure with azoospermia, amenorrhea, or anovulatory cycles has been reported in patients treated for various diseases [1-3]. Cyclophosphamide, an alkylating drug, is widely used as an antineoplastic or immunosuppressive agent. Severe gonadal failure with transient or permanent azoospermia is found in 50% to 90% of men treated with cyclophosphamide [6, 7… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 40 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 19 references

Immune suppressive treatment of membranous glomerulonephritis

  • A Faedda R. Satta, L Bosincu, M Pirisi, E. Bartoli
  • J Nephrol
  • 1995
1 Excerpt

Thyroid function in thalassemic patients after bone marrow transplantation

  • A Masala, S Alagna, D Gallisai, C Burrai, PP Rovasio, A Ginanni
  • J Nucl Biol Med
  • 1994
1 Excerpt

The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation

  • ED Kreuser, D Klingmuller, E. Thiel
  • Eur Urol
  • 1993
1 Excerpt

Analogues du LH-RH et protection contre la toxicite gonadique des traitements anticancereux

  • P Carde, C Lejeune, E Duiloust, JF Velez de la Calle, N Mathieu-Tubiana, C. Lhomme
  • Contrac Fertil Sexual
  • 1989
1 Excerpt

Similar Papers

Loading similar papers…